Bank of America’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18
| Closed | -$79 | – | 8806 |
|
|
2025
Q1 | $79 | Hold |
18
| – | – | ﹤0.01% | 7884 |
|
|
2024
Q4 | $72 | Buy |
18
+3
| +20% | +$12 | ﹤0.01% | 7809 |
|
|
2024
Q3 | $60 | Sell |
15
-1
| -6% | -$4 | ﹤0.01% | 7810 |
|
|
2024
Q2 | $59 | Buy |
+16
| New | +$64 | ﹤0.01% | 7808 |
|
|
2023
Q1 | – | Sell |
-2
| Closed | -$26 | – | 8419 |
|
|
2022
Q4 | $26 | Sell |
2
-1,169
| -100% | -$16.6K | ﹤0.01% | 7934 |
|
|
2022
Q3 | $26K | Sell |
1,171
-2,598
| -69% | -$71.3K | ﹤0.01% | 6942 |
|
|
2022
Q2 | $111K | Buy |
3,769
+3,738
| +12,058% | +$112K | ﹤0.01% | 6421 |
|
|
2022
Q1 | $1K | Buy |
+31
| New | +$1.1K | ﹤0.01% | 8158 |
|
|
2021
Q3 | – | Sell |
-4
| Closed | – | – | 8484 |
|
|
2021
Q2 | $0 | Buy |
4
+2
| +100% | +$51 | ﹤0.01% | 8190 |
|
|
2021
Q1 | $0 | Buy |
+2
| New | +$61 | ﹤0.01% | 7884 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7388 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7402 |
|
|
2017
Q1 | – | Sell |
-1
| Closed | -$1K | – | 7297 |
|
|
2016
Q4 | $1K | Buy |
+1
| New | +$747 | ﹤0.01% | 6937 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 7417 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 8218 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 8261 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 7550 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 7755 |
|
|
2013
Q3 | – | Sell |
-2
| Closed | -$13K | – | 8073 |
|
|
2013
Q2 | $13K | Buy |
+2
| New | +$10.6K | ﹤0.01% | 7102 |
|
Bank of America's NURO Position: Q2 2025 in Review
Bank of America sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q2 2025, closing a stake of 18 shares — an estimated $79 sold.
Bank of America first reported a position in NURO in Q2 2013 and held it in 12 quarters. The position peaked at $111K in Q2 2022. 0 funds tracked by Wall St. Rank hold NURO as of Q2 2025.
- Bank of America reported no remaining NeuroMetrix, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- Bank of America sold 18 NeuroMetrix, Inc. Common Stock shares in Q2 2025, an estimated $79.
- Bank of America first reported a position in NeuroMetrix, Inc. Common Stock in Q2 2013 and held it in 12 quarters.
- Bank of America's NeuroMetrix, Inc. Common Stock position peaked at $111K in Q2 2022.
- 0 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q2 2025.
Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.